Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023

Rhea-AI Summary

Allurion Technologies, Inc. (NYSE: ALUR) will report financial results for Q3 2023 on November 13, 2023. A conference call will be held at 8:30 AM ET on the same day to discuss financial results and provide a business update. Access details for the call and webcast are available on Allurion's Investor Relations website.

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will report financial results for the third quarter 2023 on Monday, November 13, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:30 AM ET.

To access the conference call by telephone, please dial (888) 330-3417 (domestic) or +1 646 960 0804 (international). To listen to the conference call via live audio webcast, please visit the Events section of Allurion’s Investor Relations website at Allurion - Events & Presentations.

A replay of the conference call will be available by telephone by dialing (800) 770 2030 (domestic) or +1 647 362 9199 (international) and using Access Code 1905455. The archived webcast will also be available on Allurion’s Investor Relations website mentioned above.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan, whether it is gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231106153567/en/

US Media

Brian Ruby

ICR

203-682-8268

brian.ruby@icrinc.com

Global Media

Cedric Damour

PR Manager

+33 7 84 21 02 20

cdamour@allurion.com

Investors

Mike Cavanaugh

ICR Westwicke

617-877-9641

mike.cavanaugh@westwicke.com

Source: Allurion Technologies, Inc.

FAQ

When will Allurion Technologies report its financial results for Q3 2023?

Allurion Technologies will report its financial results for Q3 2023 on November 13, 2023.

What time will the conference call be held on November 13, 2023?

The conference call will be held at 8:30 AM ET on November 13, 2023.

How can I access the conference call by telephone?

To access the conference call by telephone, dial (888) 330-3417 (domestic) or +1 646 960 0804 (international).

Where can I listen to the conference call via live audio webcast?

You can listen to the conference call via live audio webcast in the Events section of Allurion's Investor Relations website.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be available by telephone and using Access Code 1905455. The archived webcast will also be available on Allurion's Investor Relations website.